Convalescent Plasma News and Research

RSS
Neutralizing nanobodies effective against SARS-CoV-2 variants

Neutralizing nanobodies effective against SARS-CoV-2 variants

Study maps crucial component of long-term immune response to SARS-CoV-2

Study maps crucial component of long-term immune response to SARS-CoV-2

Impact of type I interferon (IFN) autoantibodies in critical COVID-19

Impact of type I interferon (IFN) autoantibodies in critical COVID-19

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Researcher find an emergent SARS-CoV-2 variant in California

Researcher find an emergent SARS-CoV-2 variant in California

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization

Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization

Delayed detection of oral fluid anti-SARS-CoV-2 antibodies increases the time to viral clearance

Delayed detection of oral fluid anti-SARS-CoV-2 antibodies increases the time to viral clearance

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Early antibody response predicts COVID-19 outcome

Early antibody response predicts COVID-19 outcome

Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers

Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

New SARS-CoV-2 B.1.526 variant emerges in New York

New SARS-CoV-2 B.1.526 variant emerges in New York

South African SARS-CoV-2 variant partly resistant to neutralization by mRNA vaccine, says study

South African SARS-CoV-2 variant partly resistant to neutralization by mRNA vaccine, says study

Researchers develop new tool for predicting the effects of SARS-CoV-2 missense variants

Researchers develop new tool for predicting the effects of SARS-CoV-2 missense variants

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Researchers investigate the duration of the immune response to SARS-CoV-2

Researchers investigate the duration of the immune response to SARS-CoV-2

Study reports lasting immune response in convalescent COVID-19 patients

Study reports lasting immune response in convalescent COVID-19 patients

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro